Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy

Tomasz M. Beer, Mark Garzotto, Kristi M. Eilers, Dianne Lemmon

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences